Kamada, Ltd.
Nasdaq KMDA · Rehovot, Israel
Works in Genetic & rare · GI & liver · Infectious disease · Respiratory
Kamada, Ltd. is a clinical trial sponsor based in Rehovot, Israel, listed as Nasdaq KMDA. It has no active clinical trials as lead sponsor; its trials since 2021 were in Genetic & rare, GI & liver, Infectious disease and Respiratory. Since 2021 it has completed 4 trials and stopped 1 early. Its FDA record on file shows compliance actions.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · Nasdaq KMDA
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
Questions about Kamada, Ltd
No warning letter naming Kamada, Ltd is on file. FDA has published other compliance actions naming it.
Kamada, Ltd has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 4 trials and stopped 1 early.
Kamada, Ltd is based in Rehovot, Israel and is listed as Nasdaq KMDA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Kamada, Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-12.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Kamada, Ltd..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.